Does ATORVASTATIN Cause Hyperammonaemic encephalopathy? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hyperammonaemic encephalopathy have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.
15
Reports of Hyperammonaemic encephalopathy with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
1
Deaths
15
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From ATORVASTATIN?
Of the 15 reports, 1 (6.7%) resulted in death, 15 (100.0%) required hospitalization.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which ATORVASTATIN Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM